Prostamax is one of the Khavinson short peptides. Nearly all published work is animal or cell research from a small number of Russian groups.

Prostamax

Animal studies only

Almost all the research is in animals. We do not know if the same thing happens in people.

A short peptide from Russian research, studied in animals for prostate tissue.

The basics

What is it?: Prostamax is one of the Khavinson short peptides. Nearly all published work is animal or cell research from a small number of Russian groups.

No. Pharmacies are not on record as being allowed to make this into a medicine.

The FDA has not approved this as a medicine.

Not FDA approved and not on the U.S. compounding list. A doctor cannot prescribe it.

Official status: Not on the 503A bulks list. Checked 2026-08-04.

Lab suppliers we list: 2

Taken word for word from the studies and trials listed on this page. This is not a recommendation and not a dose for anyone to take.

These are doses given to animals, usually per kilogram of body weight. They do not convert directly to a human dose.

0.05 ng
rats ·
[The tissue-specific effect of synthetic peptides-biologic regulators in organotypic tissues culture in young and old rats].Advances in gerontology = Uspekhi gerontologii · 2006
“The peptide effective concentration of 0.05 ng/ml showed a stimulating effect in appropriate tissue cultures as compared to the control explants in all groups of rats.”